Assay of erythrocyte membrane fatty acids. Effects of storage time at low temperature.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 11289711)

Published in Int J Clin Lab Res on January 01, 2000

Authors

L Di Marino1, A Maffettone, P Cipriano, E Celentano, R Galasso, C Iovine, F Berrino, S Panico

Author Affiliations

1: Department of Clinical and Experimental Medicine, Federico II University Medical School, Naples, Italy.

Articles by these authors

General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49

The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA (1997) 6.32

Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20

EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol (2003) 5.78

Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut (2000) 4.02

EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol (2003) 3.88

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81

Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol (1997) 3.39

Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer (2005) 3.04

Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia (2010) 2.91

Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia (2006) 2.53

Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43

XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis (2001) 2.35

Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr (2002) 2.25

Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study. BMJ (2005) 2.22

Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer (2011) 2.20

Patterns of lung cancer risk according to type of cigarette smoked. Int J Cancer (1984) 2.07

Variations in survival from breast cancer in Europe by age and country, 1978-1989. EUROCARE Working Group. Eur J Cancer (1998) 2.04

High endogenous estradiol is associated with increased venous distensibility and clinical evidence of varicose veins in menopausal women. J Vasc Surg (2000) 2.03

Consumption of sweet beverages and type 2 diabetes incidence in European adults: results from EPIC-InterAct. Diabetologia (2013) 1.93

Age at menarche in relation to adult height: the EPIC study. Am J Epidemiol (2005) 1.88

Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology (2000) 1.86

Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe. Eur J Cancer (2011) 1.84

Triazine herbicides and ovarian epithelial neoplasms. Scand J Work Environ Health (1989) 1.81

Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer (2003) 1.79

Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst (1996) 1.77

Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer (2001) 1.76

Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. Diabetologia (2007) 1.73

Cancer prevalence in European registry areas. Ann Oncol (2002) 1.72

Cancer of the larynx/hypopharynx, tobacco and alcohol: IARC international case-control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France). Int J Cancer (1988) 1.69

Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study. Diabetes Care (1998) 1.67

Serum uric acid and hypertension: the Olivetti heart study. J Hum Hypertens (1994) 1.66

Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res (1988) 1.66

Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol (2004) 1.63

Toward a comparison of survival in American and European cancer patients. Cancer (2000) 1.63

DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis (2005) 1.54

Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects. Oncogene (2012) 1.53

Modifying risk of developing lung cancer by changing habits of cigarette smoking. Br Med J (Clin Res Ed) (1984) 1.50

Effects of transportation and delay in processing on the stability of nutritional and metabolic biomarkers. Nutr Cancer (2000) 1.49

Relationship of alcohol intake and sex steroid concentrations in blood in pre- and post-menopausal women: the European Prospective Investigation into Cancer and Nutrition. Cancer Causes Control (2006) 1.47

Fruit and vegetable intake and type 2 diabetes: EPIC-InterAct prospective study and meta-analysis. Eur J Clin Nutr (2012) 1.46

Diet in the aetiology of cancer: a review. Eur J Cancer (1994) 1.45

Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC). Br J Cancer (2005) 1.44

Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study. Nutr Metab Cardiovasc Dis (2009) 1.43

Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol (2013) 1.43

Survival of women with breast cancer in Europe: variation with age, year of diagnosis and country. The EUROCARE Working Group. Int J Cancer (1998) 1.41

IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer (2006) 1.39

Mediterranean diet and type 2 diabetes risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study: the InterAct project. Diabetes Care (2011) 1.39

Increased plasma HDL-cholesterol and apo A-I in breast cancer patients undergoing adjuvant tamoxifen therapy. Clin Biochem (2000) 1.39

Ethnic differences in red blood cell sodium/lithium countertransport and metabolic correlates of hypertension: an international collaborative study. Am J Hypertens (1998) 1.39

Consumption of olive oil, butter, and vegetable oils and coronary heart disease risk factors. The Research Group ATS-RF2 of the Italian National Research Council. JAMA (1990) 1.38

Plant-based diet, serum fatty acid profile, and free radicals in postmenopausal women: the diet and androgens (DIANA) randomized trial. Int J Biol Markers (2005) 1.38

Plasma carotenoids as biomarkers of intake of fruits and vegetables: individual-level correlations in the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Clin Nutr (2005) 1.36

Variability of fish consumption within the 10 European countries participating in the European Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr (2002) 1.35

A case-control study of brain gliomas and occupational exposure to chemical carcinogens: the risk to farmers. Am J Epidemiol (1988) 1.35

Mediterranean dietary pattern and cancer risk in the EPIC cohort. Br J Cancer (2011) 1.35

Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br J Cancer (2006) 1.34

Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut (2005) 1.32

The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study. Diabetologia (2012) 1.28

Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer (2011) 1.27

Patterns of alcohol consumption in 10 European countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) project. Public Health Nutr (2002) 1.26

Vertebroplasty as treatment of aggressive and symptomatic vertebral hemangiomas: up to 4 years of follow-up. Neuroradiology (2009) 1.26

Validity for epidemiological studies of long-term cryoconservation of steroid and protein hormones in serum and plasma. Cancer Epidemiol Biomarkers Prev (1995) 1.22

Diet and coronary heart disease risk factors in a population with varied intake. The Research Group ATS-RF2 of The Italian National Research Council. Prev Med (1990) 1.22

Efficacy of screening in preventing invasive cervical cancer: a case-control study in Milan, Italy. IARC Sci Publ (1986) 1.21

Diversity of dietary patterns observed in the European Prospective Investigation into Cancer and Nutrition (EPIC) project. Public Health Nutr (2002) 1.19

A cross-sectional analysis of physical activity and obesity indicators in European participants of the EPIC-PANACEA study. Int J Obes (Lond) (2009) 1.18

Physical activity of subjects aged 50-64 years involved in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr (2002) 1.18

Proportion of lung cancers due to occupational exposure. Int J Cancer (1984) 1.18

Physical activity reduces the risk of incident type 2 diabetes in general and in abdominally lean and obese men and women: the EPIC-InterAct Study. Diabetologia (2012) 1.17

Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol (2008) 1.16

Diet, metabolic polymorphisms and dna adducts: the EPIC-Italy cross-sectional study. Int J Cancer (2000) 1.16

Mistletoe in cancer - a systematic review on controlled clinical trials. Eur J Med Res (2003) 1.16

Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial. Cancer Epidemiol Biomarkers Prev (2001) 1.15

Reliability of serum hormones in premenopausal and postmenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev (1996) 1.14

Survival and age at diagnosis of breast cancer in a population-based cancer registry. Eur J Cancer (1991) 1.13

Pancreatic duct replication is increased with obesity and type 2 diabetes in humans. Diabetologia (2009) 1.13

Comparisons of colon-cancer survival among European countries: The Eurocare Study. Int J Cancer (1995) 1.10

Erythrocyte membrane fatty acids and subsequent breast cancer: a prospective Italian study. J Natl Cancer Inst (2001) 1.10

Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women. Eur J Clin Nutr (2006) 1.10

Adherence to the mediterranean diet and risk of breast cancer in the European prospective investigation into cancer and nutrition cohort study. Int J Cancer (2012) 1.10

Gliomas and occupational exposure to carcinogens: case-control study. Am J Epidemiol (1982) 1.08

Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia (2011) 1.08

Dietary patterns in six european populations: results from EURALIM, a collaborative European data harmonization and information campaign. Eur J Clin Nutr (2000) 1.08

Modified Mediterranean diet and survival after myocardial infarction: the EPIC-Elderly study. Eur J Epidemiol (2007) 1.06

Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers. Ann Oncol (2007) 1.05

Increased islet beta cell replication adjacent to intrapancreatic gastrinomas in humans. Diabetologia (2006) 1.05

Variety in vegetable and fruit consumption and the risk of gastric and esophageal cancer in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2012) 1.05

Cooking of meat and fish in Europe--results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Clin Nutr (2002) 1.04

Mediterranean diet and incidence of hip fractures in a European cohort. Osteoporos Int (2012) 1.04